According to InfuSystem's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.31695. At the end of 2023 the company had a P/S ratio of 1.65.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.65 | 1.29% |
2022 | 1.63 | -52.62% |
2021 | 3.44 | -12.03% |
2020 | 3.91 | 87.21% |
2019 | 2.09 | 108.44% |
2018 | 1.00 | 36.07% |
2017 | 0.7372 | -10.1% |
2016 | 0.8200 | -14.07% |
2015 | 0.9543 | -9.71% |
2014 | 1.06 | 40.07% |
2013 | 0.7546 | 35.73% |
2012 | 0.5559 | -11.2% |
2011 | 0.6260 | -43.77% |
2010 | 1.11 | 5.25% |
2009 | 1.06 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Premier PINC | 1.89 | 43.72% | ๐บ๐ธ USA |
DexCom DXCM | 14.3 | 985.33% | ๐บ๐ธ USA |
CorVel Corporation
CRVL | 5.07 | 285.28% | ๐บ๐ธ USA |
Biolase
BIOL | 0.1005 | -92.37% | ๐บ๐ธ USA |